Skip to main content
. 2020 Apr 12;11(2):32–42. doi: 10.4291/wjgp.v11.i2.32

Figure 4.

Figure 4

Comparison of rates of Clinical remission and Endoscopic remission over multiple timepoints in those who switched to and remained on alternative aminosalicylate vs those who switched back and remained on balsalazide. A: Clinical remission; B: Endoscopic remission.